Follow-up studies demonstrated that ENKUR is a tumor suppressor participating in the pathogenesis of colorectal cancer (CRC), lung adenocarcinoma (LUAD), hepatocellular carcinoma (HCC) and nasopharyngeal carcinoma (NPC)17-21. This evidence concerns the gene ENKUR and nasopharyngeal carcinoma.